pause_circle_filledNot Yet Recruiting
Endometrial hyperplasia
Bayer Identifier:
22923
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
A Study to Learn How Well Mirena Works as Compared to Oral Progestin in Nonatypical Endometrial Hyperplasia in Women who have started their periods
Trial purpose
Researchers are looking for a better way to treat women with nonatypical endometrial hyperplasia (NAEH).
Endometrial hyperplasia is a condition where the lining of the uterus (called the endometrium) becomes too thick. Nonatypical means that the condition is not cancerous. It is often caused by hormone imbalances in women. Symptoms can include abnormal vaginal bleeding or irregular periods. If this condition is not treated, then it may lead to cancer.
Currently, oral progestins (OP) which are progesterone (female hormone) capsules taken by mouth, are used to treat NAEH. However, there is still a need for other treatments due to unmet needs.
The study treatment, Mirena (also known as BAY 865028), is already available as a type of birth control device. It is inserted into the uterus where it gradually releases progesterone.
In this study, researchers want to find out if Mirena works for women with NAEH. They believe it can help by keeping hormone levels balanced in the body.
The main purpose of this study is to learn how well Mirena works compared to oral in NAEH in women who have started their periods.
For this, the researchers will compare the number of participants with benign endometrium after 6 months of treatment with Mirena or oral progestins.
The study participants will be randomly divided equally into one of two treatment groups. Based on their group, participants will receive Mirena, which is inserted into the uterus at the start of the study, or they will take progestins once daily by mouth for 6 months.
Each participant will be in the study for around 10 months with up to 5 visits to the study clinic/site.
Participants will visit the study clinic:
- once before the treatment starts
- 3 times with a gap of 3 months between the visits during the treatment
- then 1 more time after the treatment ends
During the study, the doctors and their study team will:
- check participant's health by performing tests such as blood and urine tests
- perform vaginal ultrasound and hysteroscopy. Hysteroscopy is a minor surgical procedure where a thin camera will be inserted into the womb to check for any abnormality. Sampling of the endometrial lining (cells in the womb) will be done with a thin tube at the same time.
- take samples of womb (endometrial) lining
- ask the participants questions about how they are feeling and what adverse events they are having
An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatment.
Endometrial hyperplasia is a condition where the lining of the uterus (called the endometrium) becomes too thick. Nonatypical means that the condition is not cancerous. It is often caused by hormone imbalances in women. Symptoms can include abnormal vaginal bleeding or irregular periods. If this condition is not treated, then it may lead to cancer.
Currently, oral progestins (OP) which are progesterone (female hormone) capsules taken by mouth, are used to treat NAEH. However, there is still a need for other treatments due to unmet needs.
The study treatment, Mirena (also known as BAY 865028), is already available as a type of birth control device. It is inserted into the uterus where it gradually releases progesterone.
In this study, researchers want to find out if Mirena works for women with NAEH. They believe it can help by keeping hormone levels balanced in the body.
The main purpose of this study is to learn how well Mirena works compared to oral in NAEH in women who have started their periods.
For this, the researchers will compare the number of participants with benign endometrium after 6 months of treatment with Mirena or oral progestins.
The study participants will be randomly divided equally into one of two treatment groups. Based on their group, participants will receive Mirena, which is inserted into the uterus at the start of the study, or they will take progestins once daily by mouth for 6 months.
Each participant will be in the study for around 10 months with up to 5 visits to the study clinic/site.
Participants will visit the study clinic:
- once before the treatment starts
- 3 times with a gap of 3 months between the visits during the treatment
- then 1 more time after the treatment ends
During the study, the doctors and their study team will:
- check participant's health by performing tests such as blood and urine tests
- perform vaginal ultrasound and hysteroscopy. Hysteroscopy is a minor surgical procedure where a thin camera will be inserted into the womb to check for any abnormality. Sampling of the endometrial lining (cells in the womb) will be done with a thin tube at the same time.
- take samples of womb (endometrial) lining
- ask the participants questions about how they are feeling and what adverse events they are having
An adverse event is any medical problem that a participant has during a study. Doctors keep track of all adverse events, irrespective if they think it is related or not to the study treatment.
Key Participants Requirements
Sex
FemaleAge
16 - N/ATrial summary
Enrollment Goal
300Trial Dates
June 2025 - October 2026Phase
Phase 3Could I Receive a placebo
NoProducts
Mirena (Levonorgestrel IUS, BAY86-5028)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Not yet recruiting | Southern Clinical Research Associates | Metairie, LA | Metairie, 70001, United States |
Not yet recruiting | Unified Women's Clinical Research | Raleigh, NC | Raleigh, 27607, United States |
Not yet recruiting | Omni Fertility and Laser Institute | Shreveport, 71118, United States |
Not yet recruiting | Gynecologic Oncology Associates | Shreveport, 71103, United States |
Not yet recruiting | Unified Women's Clinical Research | Winston-Salem, 27103, United States |
Not yet recruiting | Clinical Research Prime | Idaho Falls, 83404, United States |
Not yet recruiting | Mesa Obstetricians and Gynecologists | Research Department | Mesa, 85206, United States |
Not yet recruiting | Affiliated Clinical Research, Inc. | Las Vegas, NV | Las Vegas, 89113, United States |
Not yet recruiting | Inova Fairfax Hospital - OBGYN | Falls Church, 22042, United States |
Not yet recruiting | Galen Obstetrics And Gynecology Ridgeside | Chattanooga, 37404, United States |
Not yet recruiting | Rutgers Robert Wood Johnson Medical School | New Brunswick, 08901, United States |
Not yet recruiting | Women's Health Alliance of Mobile | Mobile, 36604, United States |
Not yet recruiting | Cornerstone Clinic for Women | Little Rock, 72205, United States |
Not yet recruiting | Advances in Health, INC. | Houston, TX | Houston, 77030, United States |
Not yet recruiting | Physician Care Clinical Research LLC | Sarasota, FL | Sarasota, 34239, United States |
Not yet recruiting | Women's Healthcare Associates, PA | Idaho Falls, 83404, United States |
Not yet recruiting | Discovery Clinical Trials - Dallas | Dallas, 75231, United States |
Not yet recruiting | Axia Women's Health | Oaks, 19456, United States |
Not yet recruiting | ClinOhio Research Services, LLC. | Columbus, OH | Columbus, 43213, United States |
Not yet recruiting | University of Florida | Gainesville, 32608, United States |
Not yet recruiting | University of California Davis Medical Center | Sacramento, 95817, United States |
Not yet recruiting | UT Health San Antonio - UT Health Medical Arts & Research Center (MARC) | San Antonio, 78229-3931, United States |
Not yet recruiting | Johns Hopkins Outpatient Center - Obstetrics and Gynecology | Baltimore, 21287, United States |
Not yet recruiting | South Texas Clinical Research | Corpus Christi, 78404, United States |
Not yet recruiting | McGill Family Practice | Papillion, 68046, United States |
Not yet recruiting | St. Dominic's Gynecology/Oncology | Jackson, 39216, United States |
Not yet recruiting | Allen Clinical Research LLC | Gardena, 90247, United States |
Not yet recruiting | Peking Union Medical College Hospital CAMS | Beijing, 100730, China |
Not yet recruiting | Jiangxi Maternal and Child Health Hospital | Nanchang, 330006, China |
Not yet recruiting | Nanjing Medical University (NMU) - The Second Affiliated Hospital | Nanjing, 210011, China |
Not yet recruiting | Chengdu Women & Children's Central Hospital | Chengdu, 610091, China |
Not yet recruiting | Xiamen Maternity and Child Health Care Hospital | Xiamen, TBC, China |
Not yet recruiting | Women's Hospital School of Medicine Zhejiang University | Hangzhou, 310006, China |
Not yet recruiting | Nanjing Maternity and Child Health Care Hospital | Nanjing, 210004, China |
Not yet recruiting | Bosque Women's Care | Albuquerque, NM | Albuquerque, 87109, United States |
Not yet recruiting | OB/GYN Associates of Erie | Erie, 16507, United States |
Not yet recruiting | Piedmont Hospital | Atlanta, 30309, United States |
Not yet recruiting | Emerald Coast Clinical Research | Panama City, 32405, United States |
Not yet recruiting | The Woman's Place - Midlife Health | Charlottesville, 22903, United States |
Not yet recruiting | Chongqing Maternal and Child Health Care Hospital | Chongqing, China |
Not yet recruiting | Velvet Clinical Research | Burbank, 91506, United States |
Not yet recruiting | Office of Dr. Cindy Basinski, LLC | Newburgh, 47630, United States |
Not yet recruiting | Sweet Hope Research Specialty, Inc. | Hialeah, FL | Hialeah, 33016, United States |
Not yet recruiting | McFarland Clinic | Ames, 50010, United States |
Not yet recruiting | Velocity Clinical Research - Lafayette | Lafayette, 70508, United States |
Not yet recruiting | University of Alabama at Birmingham | Birmingham, 35233, United States |
Primary Outcome
- Proportion of participants with Complete Resolution (CR) of NAEHComplete Resolution will be evaluated as benign endometrium.date_rangeTime Frame:At 6 months
Secondary Outcome
- Recurrence of NAEH after CRRecurrence of NAEH on 3 months treatment free after CR at 6 monthsdate_rangeTime Frame:At 3 months follow up after 6 months treatment
- Progression after CREndometrial hyperplasia with atypia or endometrial cancer after 3 months treatment free follow up after CR at 6 monthsdate_rangeTime Frame:At 3 months follow up after 6 months treatment
- Proportion of participants having hysterectomydate_rangeTime Frame:During treatment and 3 months follow up
- Diagnosis of "benign endometrium"date_rangeTime Frame:At 6 months of treatment followed by 3 month treatment-free follow up
- Number of participants with adverse eventsAll AEs will be coded using the latest version prior to database lock of the Medical Dictionary for Regulatory Activitiesdate_rangeTime Frame:From the signing of the informed consent form (ICF) up to 3 months after the last dose of study intervention
Trial design
Trial Type
InterventionalIntervention Type
Combination ProductTrial Purpose
TreatmentAllocation
RandomizedBlinding
N/AAssignment
Parallel AssignmentTrial Arms
2